<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: fetal hemoglobin</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>New approach to sickle-cell disease shows promise in mice</title>
   	 <description>A new genetic approach to treating sickle cell disease is showing promising results in mice, report researchers from Children's Hospital Boston. By inactivating a gene they previously discovered to be important in the laboratory, they were able to boost production of a healthy fetal form of hemoglobin in the mice, potentially compensating for the defective adult hemoglobin that causes red blood cells to "sickle" and obstruct blood flow.</description>
     <link>http://www.physorg.com/news179420948.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 07 Dec 2009 15:09:46 EST</pubDate>
	 <guid isPermaLink="false">news179420948</guid>
</item>
<item>
     <title>Red grape skin extract could be new treatment for sickle cell disease patients</title>
   	 <description>An extract in red grape skin may be a new treatment for sickle cell disease, Medical College of Georgia researchers say.</description>
     <link>http://www.physorg.com/news175458089.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 22 Oct 2009 20:00:01 EST</pubDate>
	 <guid isPermaLink="false">news175458089</guid>
</item>
<item>
     <title>Researchers find new genetic target for sickle cell disease therapy</title>
   	 <description>Researchers have identified a gene that directly affects the production of a form of hemoglobin that is instrumental in modifying the severity of the inherited blood disorders sickle cell disease and thalassemia. The discovery could lead to breakthrough therapies for sickle cell disease and thalassemia, which could potentially eliminate the devastating and life-threatening complications of these diseases, such as severe pain, damage to the eyes and other organs, infections, and stroke.</description>
     <link>http://www.physorg.com/news147622782.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 04 Dec 2008 14:19:42 EST</pubDate>
	 <guid isPermaLink="false">news147622782</guid>
</item>
<item>
     <title>Gene therapy corrects sickle cell disease in laboratory study</title>
   	 <description>Using a harmless virus to insert a corrective gene into mouse blood cells, scientists at St. Jude Children's Research Hospital have alleviated sickle cell disease pathology. In their studies, the researchers found that the treated mice showed essentially no difference from normal mice. Although the scientists caution that applying the gene therapy to humans presents significant technical obstacles, they believe that the new therapy will become an important treatment for the disease.</description>
     <link>http://www.physorg.com/news147533138.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 03 Dec 2008 13:25:38 EST</pubDate>
	 <guid isPermaLink="false">news147533138</guid>
</item>


</channel>
</rss>

